| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |